Acute Lymphoblastic Leukemia- Relapse Study of the Berlin-Frankfurt-Münster Group (ALL-REZ BFM) Experience: Early Treatment Intensity Makes the Difference
- 1 February 2004
- journal article
- other
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 22 (3) , 569-570
- https://doi.org/10.1200/jco.2004.99.153
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Should Adolescents With Acute Lymphoblastic Leukemia Be Treated as Old Children or Young Adults? Comparison of the French FRALLE-93 and LALA-94 TrialsJournal of Clinical Oncology, 2003
- Differences in Outcome in Adolescents With Acute Lymphoblastic Leukemia: A Consequence of Better Regimens? Better Doctors? Both?Journal of Clinical Oncology, 2003
- Soluble l‐selectin (sCD62L) in relapsed childhood acute lymphoblastic leukaemiaBritish Journal of Haematology, 2002
- Deployment of academic subspecialists in the emerging era of primary careThe American Journal of Medicine, 1995
- Median follow-up in clinical trials.Journal of Clinical Oncology, 1991